<DOC>
	<DOCNO>NCT00620035</DOCNO>
	<brief_summary>The primary purpose study evaluate use next generation applicator instruction proper insertion Radiopaque Implant . Secondary objective include : evaluation implant removal , evaluation overall contraceptive efficacy safety Radiopaque Implant , assessment x -ray visibility Radiopaque Implant , ass participant expectation satisfaction Radiopaque Implant .</brief_summary>
	<brief_title>A Multicenter Trial Evaluate Insertion Characteristics Radiopaque Etonogestrel Implant Using Next Generation Applicator ( 34530 ) ( P05702 )</brief_title>
	<detailed_description />
	<mesh_term>Etonogestrel</mesh_term>
	<mesh_term>Desogestrel</mesh_term>
	<criteria>Woman least ( &gt; = ) 18 old ( &lt; = ) 40 year age time screening ; Good physical mental health ; Regular cycle usual length 24 35 day ; Body mass index &gt; = 18 &lt; = 35 kg/m^2 ; Willing give informed consent writing . Contraindications : know suspected pregnancy ; active venous thromboembolic disorder ( e.g . deep vein thrombosis , pulmonary embolism ) ; presence history severe hepatic disease long liver function value return normal ; malignancy premalignancy , sexsteroidinfluenced ; undiagnosed vaginal bleeding ; hypersensitivity component Radiopaque Implant . Hypertension , i.e . systolic blood pressure &gt; 140 mmHg and/or diastolic blood pressure &gt; 90 mmHg ; A history pregnancy previous use sex steroid : jaundice and/or severe pruritus related cholestasis , gallstone formation , porphyria , systemic lupus erythematosus , haemolytic uraemic syndrome , Sydenham 's chorea , herpes gestationis , otosclerosisrelated hearing loss ; Present use use 2 month prior start Radiopaque Implant one follow drug : phenytoin , phenobarbital , primidone , carbamazepine , rifampicin , oxcarbazepine , topiramate , felbamate , ritonavir , nelfinavir , griseofulvin herbal remedy St John 's wort ; Administration investigational drug within 2 month prior start Radiopaque Implant</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>August 2015</verification_date>
</DOC>